Venetoclax-resistant monocytic AML had a distinct transcriptomic profile, reduced expression of BCL2, and showed to rely on MCL1 for oxidative phosphorylation (OXPHOS) and survival. This evidence concerns the gene MCL1 and acute myeloid leukemia.